NeoChord (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2015
- Vertical
- Medical Technology
- Funding URL
- View Funding Page
- Funding Amount:
- $20,000,000
Company Info
- Company Description
- NeoChord is a privately held medical technology company focused on advancing the treatment of mitral regurgitation. The Company received CE marking in December 2012 for the DS1000 device for minimally invasive mitral valve repair via surgical implantation of artificial chordae tendinae.
- Market
- Mitral Regurgitation Treatment
- Location
- Eden Prairie, Minnesota, USA
- Coinvestors
- Baird Capital, Deerfield Management Company, L.P., Heron Capital, TGAP Ventures